 IMAC Holdings, Inc. IMAC, a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced results from an extensive internal analysis of treatment outcomes for musculoskeletal conditions performed at IMAC Regeneration Centers, which showed approximately 81 of IMAC patients reported improvement in movement. IMAC analyzed functional disabilities primarily affecting the knees, lower back, neck, shoulders, hips, legs and ankles. IMAC examined patient functional improvement following treatment at IMAC Regeneration Centers between 2017 and 2019 utilizing standardized disability indexes for the categories listed above. 